A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD

NCT07678827 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder
Attention-Deficit / Hyperactivity Disorder
ADHD

Interventions

DRUG: AK-D101
DRUG: Placebo

Sponsor

Alvogen Korea